Nosocomial fungal infections: Candidemia

Diagnostic Microbiology and Infectious Disease

Volumn 34, Issue 3, 1999, Pages 213-220

  Verduyn Lunel, Frans M ^a   Meis, Jacques F G M ^a   Voss, Andreas ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE;

CANCER CHEMOTHERAPY; CANDIDA; CANDIDA ALBICANS; CANDIDA LUSITANIAE; CANDIDIASIS; CONFERENCE PAPER; DISEASE TRANSMISSION; DRUG RESISTANCE; FUNGUS IDENTIFICATION; GENOTYPE; GRANULOCYTOPENIA; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; FUNGEMIA; HUMANS;

EID: 0032994005     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00035-8     Document Type: Conference Paper

References (97)

1. Abi-Said D, Anaissie E, Uzun U, Raad I, Pinzcowski H, Vartivarian S (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24:1122-1128.
2. Akova M. Akalin HE, Uzun O, Gur D (1991) Emergency of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole. Eur J Clin Microbiol Infect Dis 10:598-599.
3. Akova M, Akalin HE, Uzun O, Hayran M, Tekuzman G, Kansu E, Aslan S, Telatar H (1994) Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: Factors influencing the outcome. Clin Infect Dis 18:298-304.
4. Anaissie EJ, Bodey GP, Kantarjian HM, David C, Kyle B, Bow EJ, Defelice R, Downs N, File T, Karam G, Potts D, Shelton M, Sugar AM (1991) Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B. Am J Med 91:142-150.
5. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JE, Tolson J, Henderson T, Martine WJ (1991) Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 91(suppl):86S-89S.
6. Barchiesi F, Morbiducci V, Ancarani F, Scalise G (1993) Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients (letter). Eur J Epidemiol 9:455-456.
7. Barnett JA, Payne RW, Yarrow D (1991) Yeasts-characteristics and Identification. New York: Cambridge University Press.
8. Beck Sague CM, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 167:1247-1251.
9. Betremieux P, Chevrier S, Quindos G, Sullivan D, Polonelli L, Guiguen C (1994) Use of DNA fingerprinting and biotyping methods to study a Candida albicans outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 13:899-905.
10. Blinkhorn RJ, Adelstein D, Spagnulo PJ (1989) Emergence of a new opportunistic pathogen. Candida lusitaniae. J Clin Microbiol 27:236-240.
11. Bodey GP, Anaissie EJ, Edwards JE (1993) Definitions of Candida infections. In: Candidiasis. Pathogenesis, Diagnosis, and Treatment. Ed, Bodey GP. New York: Raven Press, pp. 407-408.
12. Bow EJ, Loewen R, Cheang MS, Schacter B (1995) Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: The pathogenetic role of the antileukemic regimen. Clin Infect Dis 21:361-369.
13. Brooks RG (1989) Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 149:2226-2228.
14. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL (1989) Risk factors for nosocomial candidemia: A case-control study in adults without leukemia. Am J Med 87:614-620.
15. Burnie JP, Matthews R, Lee W, Philpott-Howard J, Brown R, Damani N, Breuer J, Honeywell K, Jordans Z (1987) Four outbreaks of nosocomial systemic candidiasis. Epidemiol Infect 99:201-211.
16. Curry CR, Quie PG (1971) Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med 285:1221-1225.
17. De Pauw BE, Raemaekers JMM, Donnelly JP, Kullberg BJ, Meis JFGM (1995) An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy. Ann Hematol 70:83-87.
18. Doebbeling BN, Hollis RJ, Isenberg HD, Wenzel RP, Pfaller MA (1991) Restriction fragment analysis of a Candida tropicalis outbreak of sternal wound infection. J Clin Microbiol 29:1268-1270.
19. Doebbeling BN, Lehmann PF, Hollis RJ, Wu L, Widmer A, Voss A, Pfaller MA (1993) Comparison of pulsed-field electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. Clin Infect Dis 16:377-383.
20. Edwards JE, Filler SG (1992) Current strategies for treating invasive candidiasis: Emphasis on infections in nonneutropenic patients. Clin Infect Dis 14(suppl):S106-S113.
21. Fan Havard P, Capano D, Smith SM, Mangia A, Eng RH (1991) Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 35:2302-2305.
22. Finkelstein R, Reinhertz BA, Hashman N, Merzbach D (1993) Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit. Infect Control Hosp Epidemiol 14:587-590.
23. Francis P, Walsh TJ (1992) Evolving role of flucytosine in immunocompromised patients: New insights into safety, pharmacokinetics, and antifungal therapy. Clin Infect Dis 15:1003-1018.
24. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC (1992) Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 15:414-121.
25. Goodrich JM, Reed EC, Mori M (1991) Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis 164:731-740.
26. Gorbach SL, Nahas L, Lerner PI, Weinstein L (1967) Studies of intestinal microflora. Gastroenterology 53:845-855.
27. Guiot HFL, Fibbe WE, van't Wout JW (1994) Risk factors for fungal infection in patients with malignant hematological disorders: Implications for empirical therapy and prophylaxis. Clin Infect Dis 18:525-532.
28. Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C (1987) Mycoses caused by Candida lusitaniae. Rev Infect Dis 9:1006-1012.
29. Hunter PR, Harrison GAJ, Fraser CAM (1990) Cross-infection and diversity of Candida albicans strain carriage in patients and nursing staff on an intensive care unit. J Med Vet Mycol 28:317-325.
30. Isenberg HD, Tucci V, Cintron F, Singer C, Weinstein GS, Tyras DH (1989) Single-source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 27:2426-2428.
31. Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29(suppl A): 19-24.
32. Karabinis A, Hills C, Leclercq B, Tancrede C, Baume D, Andremont A (1988) Risk factors for candidemia in cancer patients: A case-control study. J Clin Microbiol 26:429-432.
33. Kauffman CA, Bradley SF, Ross SC, Weber DR (1991) Hepatosplenic candidiasis: Successful treatment with fluconazole. Am J Med 91:137-141.
34. King D, Rhine Chalberg J, Pfaller MA, Moser SA, Merz WG (1995) Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J Clin Microbiol 33:1467-1470.
35. Komshian SV, Uwaydah AK, Sobel JD, Crane LR (1989) Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 11:379-390.
36. Krause W, Matheis H, Wulf K (1969) Fungemia and funguria after oral administration of Candida albicans. Lancet 1:598-599.
37. Kujath P, Lerch K, Kochendoerfer P, Boos C (1993) Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection 21:376-382.
38. Kullberg BJ, Voss A (1996) Het veranderend patroon van Candida-infecties: Andere soorten en meer resistentie. Ned Tijdschr Geneeskd 140:148-151.
39. Lecciones JA, Lee JW, Navarro EE (1992) Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes. Clin Infect Dis 14:875-883.
40. Lehrer RI, Cline MJ (1971) Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer. Cancer 27:1211-1217.
41. Marina NM, Flynn PM, Rivera GK, Hughes WT (1991) Candida tropicalis and Candida albicans fungemia in children with leukemia. Can J Microbiol 68:594-599.
42. McGinley KJ, Larson EL, Leyden JJ (1988) Composition and density of microflora in the subungual space of the hand. J Clin Microbiol 26:950-953.
43. Meis JFGM, Ruhnke M, De Pauw BE, Odds FC, Siegert W, Verweij PE (1999) Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 5:150-
44. (also available from URL: http://www.cdc.gov/ ncidod/EID/eid.htm).
45. Meunier-Carpentier F, Kiehn TE, Armstrong D (1981) Fungemia in the immunocompromised host: Changing patterns, antigenemia, high mortality. Am J Med 71:363-370.
46. Milatovic D, Voss A (1992) Efficacy of fluconazole in the treatment of systemic fungal infections. Eur J Clin Microbiol Infect Dis 11:395-402.
47. Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T (1994) Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: Persistence of Candida albicans strains with the same genotype. J Clin Microbiol 32:1115-1118.
48. Minagi S, Miyake Y, Inagaki K, Tsuru H, Suginaka H (1985) Hydrophobic interaction in Candida albicans and Candida tropicalis: Adherence to various denture base resin materials. Infect Immun 47:11-14.
49. Ng, TTC, Denning DW (1993) Fluconazole resistance in Candida in patients with AIDS - A therapeutic approach. J Infect 26:117-125.
50. Odds FC (1987) Candida infections: An overview. Crit Rev Microbiol 15:1-5.
51. Odds FC (1993) Resistance of yeast to azole-derivative antifungals. J Antimicrob Chemother 31:463-471.
52. Pappagianis D, Collins MS, Hector R, Remington J (1979) Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother 16:123-126.
53. Paya CV (1993) Fungal infections in solid-organ transplantation. Clin Infect Dis 16:677-688.
54. Pertowski CA, Baron RC, Lasker BA, Benson Werner S, Jarvis WR (1995) Nosocomial outbreak of Candida albicans sternal wound infections following cardiac surgery traced to a scrub nurse. J Infect Dis 172:817-822.
55. Pfaller MA, Wenzel RP (1992) Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 11:287-291.
56. Pfaller MA, Messer SA, Hollis RJ (1994) Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae. Diagn Microbiol Infect Dis 20:127-133.
57. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP (1998a) National surveillance of nosocomial blood stream infections due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 31:327-332.
58. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP, and the SCOPE Participant Group (1998b) National surveillance of nosocomial blood stream infections due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 30:121-129.
59. Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA, for the SENTRY Participant Group (1998c) International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and anti-fungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY program. J Clin Microbiol 36:1886-1889.
60. Pfaller MA, Messer SA, Houston A, Rangel-Frausto MS, Wiblin T, Blumberg HM, Edwards JE, Jarvis W, Martin MA, Neu HC, Saiman L, Patterson JE, Dibb JC, Roldan CM, Rinaldi MG, Wenzel RP (1998d) National epidemiology of mycoses survey: A multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 31:289-296.
61. Pfaller MA, Messer SA, Mollis RJ, Jones RN, Doern GV, Brandt ME, Hajjeh RA (1999) Trends in species distribution and susceptibility to fluconazole among bloodstream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 33:217-222.
62. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751-758.
63. Plouffe JF, Brown DG, Silva J, Eck T, Stricof RL, Fekety R Jr (1977) Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch Int Med 137:1686-1689.
64. Powderly WG, Kobayashi GS, Herzig GP, Medoff G (1988) Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 84:826-831.
65. Price MF, LaRocco MT, Gentry LO (1994) Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 38:1422-1424.
66. Rangel-Frausto MS, Houston AK, Bale MJ, Fu C, Wenzel RP (1994) An experimental model for study of Candida survival and transmission in human volunteers. Eur J Clin Microbiol Infect Dis 15:590-595.
67. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP (1990) Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 28:2733-2738.
68. Redding S, Smith J, Farinacci G, Rinaldi MG, Fothergill A, Rhine Chalberg J, Pfaller MA (1994) Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: Documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 18:240-242.
69. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL (1998) The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: Results of population-based laboratory active surveillance. Clin Infect Dis 27:1138-1147.
70. Rentz AM, Halpern MT, Bowden R (1998) The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 27:781-788.
71. Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD, for the Candidemia Study Group and the NIAID Mycosis Study Group (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325-1330.
72. Rex JH, Bennett JE, Sugar AM, Pappas PG, Serody J, Edwards JE, Washburn RG, NIAID Mycoses Study Group, and Candidemia Study Group (1995a) Intravascular catheter exchange and duration of candidemia. Clin Infect Dis 21:994-996.
73. Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD, NIAID Mycosis Study Group and the Candidemia Study Group (1995b) Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob Agents Chemother 39:40-44.
74. Rex JH, Rinaldi MG, Pfaller MA (1995c) Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39:1-8.
75. Ruechel R (1990) Virulence factors of Candida species. In: Oral Candidiasis. Eds, Samaranayake LP, MacFarlane TW. London: Wright, pp. 47-65.
76. Sanchez V, Vazquez JA, Barth Jones D, Dembry L, Sobel JD, Zervos MJ (1992) Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol 30:3005-3008.
77. Sandven P, Bevanger L, Digranes A, Gaustad P, Haukland HH, Steinbakk M, and the Norwegian Yeast Study Group (1998) Constant low rate of fungemia in Norway, 1991 to 1996. J Clin Microbiol 36:3455-3459.
78. Schaberg DR, Culver DH, Gaynes RP, Cluver DH (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91(suppl):72S-75S.
79. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL (1984) Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Can J Microbiol 53:411-119.
80. Seelig MS (1966) The role of antibiotics in the pathogenesis of Candida infections. Am J Med 40:887-917.
81. Sobel JD, Myers PG, Kaye D, Levinson ME (1981) Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Infect Dis 14:76-82.
82. Solomkin JS (1993) Pathogenesis and management of Candida infection syndromes in non-neutropenic patients. New Horiz 1:202-213.
83. Stevens DA, Odds FC, Scherer S (1990) Application of DNA typing methods to Candida albicans epidemiology and correlation with phenotype. Rev Infect Dis 12:258-266.
84. Strausbaugh LJ, Sewell DL, Wark TT, Pfaller MA, Heitzman T, Tjoelker R (1994) High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol 32:2299-2300.
85. Tan CS, Wintermans RG, de Hoog GS, Engel HW, IJzerman EP (1992) Verschuivingen in het soortenspectrum van mycosen in Nederland in het tijdvak 1970-1990. Ned Tijdschr Geneeskd 136:631-637.
86. Verfaillie C, Weisdorf D, Haake R, Hostetter M, Ramsay NK, McGlave P (1991) Candida infections in bone marrow recipients. Bone Marrow Transplant 8:177-184.
87. Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN (1994) Investigation of the sequence of colonization and candidaemia in nonneutropenic patients. J Clin Microbiol 32:975-980.
88. Voss A, Kluytmans JAJW, Koeleman JGM, Spanjaard L, Vandenbroucke-Grauls CMJE, Verbrugh HA, Vos MC, Weersink AYL, Hoogkamp-Korstanje JAA, Meis JFGM (1996) Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 15:909-912.
89. Voss A, Le Noble JLML, Verduyn Lunel FM, Foudraine N, Meis JFGM (1997) Candidemia in intensive care unit patients: Risk factors for mortality. Infection 25:8-11.
90. Weems JJ Jr (1992) Candida parapsilosis: Epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility Clin Infect Dis 14:756-766.
91. Weese-Mayer DE, Fondriest DW, Brouillette RT, Shulman ST (1987) Risk factors associated with candidemia in the neonatal intensive care unit: A case-control study. Pediatr Infect Dis J 6:190-196.
92. Wenzel RP (1995) Nosocomial candidemia: Risk factors and attributable mortality. Clin Infect Dis 20:1531-1534.
93. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148:2642-2645.
94. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1989) Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 149:2349-2353.
95. Wingard JR, Merz WG, Rinaldi MG, Johnson RT, Karp JE, Saral R (1991) Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274-1277.
96. Wingard JR (1995) Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20:115-125.
97. Young RC, Bennett JE, Geelhoed GW, Levine AS (1974) Fungemia with compromised host resistance. Ann Intern Med 80:605-612.